ARTICLE | Finance
Drawn and quartered
Biotech winners, losers in 3Q15
October 5, 2015 7:00 AM UTC
There was no joy to be had in 3Q15, as every biotech market cap band fell by at least 15%. After the carnage only one group - companies valued north of $5 billion - are in the black for the year.
The big caps are clinging to a 0.2% gain through the first nine months of the year despite shedding 15.1% in the third quarter (see "Results by Market Cap," page 15)...